Pills that rival biologics, weight-loss drugs paired with psoriasis treatment and a phase 3 win for a personalized mRNA ...
Accepted for Priority Review with a PDUFA target action date of February 4, 2027; being granted Priority Review by the FDA underscores the ...
SeaStar Medical Holding Corp. ( ICU ), a commercial-stage healthcare company, said the U.S. FDA has granted Breakthrough Device Designation to its Selective Cytopheretic Device (SCD) therapy for ...
HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights, today announced that the U.S. Food and Drug Administration ...
Reinsurance Group of America upgraded to Buy after strong underwriting and investment returns. See here for a detailed ...
Anthropic's Claude autonomously found a CRISPR-like enzyme system called ART. Its function is unproven, and several ...
US FDA accepts and grants priority review status to BridgeBio’s NDA of oral infigratinib for children with achondroplasia: Palo Alto, California Wednesday, October 7, 2026, 17:0 ...
Today it holds ex-China rights to the world’s first approved once-daily oral Factor B inhibitor and, as of this morning, to a breakthrough-designated cancer drug. NXP200, the company’s oral, ...
UCB, a global biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) to CIMZIA® (certolizumab pegol) for the ...
Wellbeing Magazine on MSN
Gelagen Gummies Reviews 2026 – Legit Korean-Inspired Beauty Gummy Or Overhyped? (Consumer Research)
Gelagen is a daily beauty gummy built around biotin and a range of skin-supporting vitamins. It has no collagen peptides. The ...
Global Medical Device Clinical Trials Market was valued at USD 17.52 Billion in 2025 and is expected to grow at 6.58% CAGR to reach USD 33.14 Billion by 2035.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results